Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Marra

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 25, 2018
Design, Synthesis and Biological Evaluation of 1H-1,2,3-Triazole-Linked-1H-Dibenzo[b,h]xanthenes as Inductors of ROS-Mediated Apoptosis in the Breast Cancer Cell Line MCF-7Carolina S Bortolot, Luana da S M Forezi, Roberta K F Marra, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2017
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLDS Petta, V W-S Wong, C Cammà, et al.
Molecules (Basel, Switzerland)|November 3, 2012
4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected diseaseRoberta K F Marra, Alice M R Bernardino, Tathiane A Proux, et al.
European Journal of Medicinal Chemistry|December 7, 2015
Synthesis and antimalarial activity of quinones and structurally-related oxirane derivativesPaula F Carneiro, Maria C R F Pinto, Roberta K F Marra, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
ESMO Open|June 18, 2021
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinomaI G Rapposelli, S Shimose, T Kumada, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 25, 2018
Design, Synthesis and Biological Evaluation of 1H-1,2,3-Triazole-Linked-1H-Dibenzo[b,h]xanthenes as Inductors of ROS-Mediated Apoptosis in the Breast Cancer Cell Line MCF-7Carolina S Bortolot, Luana da S M Forezi, Roberta K F Marra, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2017
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLDS Petta, V W-S Wong, C Cammà, et al.
Molecules (Basel, Switzerland)|November 3, 2012
4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected diseaseRoberta K F Marra, Alice M R Bernardino, Tathiane A Proux, et al.
European Journal of Medicinal Chemistry|December 7, 2015
Synthesis and antimalarial activity of quinones and structurally-related oxirane derivativesPaula F Carneiro, Maria C R F Pinto, Roberta K F Marra, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
ESMO Open|June 18, 2021
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinomaI G Rapposelli, S Shimose, T Kumada, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 13